PEP delayed until Q4 (page 3 yellow banner), and looks like sales won't be progressing until late Q4, rather than early Q4 like previously stated. If I'm understanding it all correctly, no big surprises, and kick the can down the road just a little bit more while they get everything set up.
Launch Meeting late Jan, but looking like a 1M size group targeted from December, so sales are unlikely to be overwhelming for Q4 results. I guess if 5% of 1 Mil - its 50k prescriptions will be a good start.
Ann: Botanix Webinar - Presentation Copy, page-2
-
- There are more pages in this discussion • 295 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.005(1.43%) |
Mkt cap ! $627.0M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 36.0¢ | 34.5¢ | $1.255M | 3.601M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 206282 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 316320 | 5 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |